Wednesday, September 30
President Donald Trump called Federal Reserve Chair Jerome Powell "terrible" and said he knows three or four people who are contenders for the next chair of the Federal Reserve. "I know within three or four people who I'm going to pick," Trump told reporters when asked if he is interviewing candidates to replace Powell.
Indian pharmaceutical and biotech sectors have started witnessing tangible benefits from the global shift away from China, as early signs of the China+1 strategy materialising emerge, according to a recent Goldman Sachs report.Some pharmaceutical and biotech companies report that they have started witnessing the conversion of earlier enquiries and Requests for Quotations (RFQs) into pilot projects and small contracts.The 'China Plus One' strategy is a business technique in which corporations diversify their manufacturing and supply chains by expanding into countries other than China while still keeping a presence in China.The report was prepared based on the outcome of the '2nd annual India CRO/CDMO trip' event in Bangalore and Hyderabad.The credit rating firm, in its equity report, added
Tata Sons and Singapore Airlines invested Rs 9,558 crore in loss-making Air India in 2024-25, with the promoters pumping in Rs 4,306 crore alone in March this year.The airline, being piloted by Tatas since January 2022, has embarked on an ambitious five-year transformation plan. In November 2024, Vistara -- a joint venture between Tatas and Singapore Airlines -- was merged with Air India, following which the Singaporean carrier acquired a 25.1 per cent stake in Air India.In response to queries about fundraising, an Air India spokesperson told PTI on Wednesday that its shareholders have together infused fresh capital of more than Rs 9,500 crore in 2024-25 to meet the airline's capital expenditure requirements.Tata Sons invested Rs 3,224.82 crore, and Singapore Airlines put in Rs 6,333.18 cr
